TIMP1 and Miyoshi myopathy: Collectively, our findings suggest that MM-derived TIMP1 may phenotypically convert fibroblasts, similar to cancer-associated fibroblasts, and that TIMP1 may tune the MM microenvironment to promote its expansion by activating fibroblast invasion capacity.